key: cord-0078346-3cgexvm6 authors: Quesada, Odayme; Van Hon, Logan; Madan, Mina; Yildiz, Mehmet; Sanina, Cristina; Davidson, Laura; Htun, Wah Wah; Saw, Jacqueline; Garcia, Santiago; Dehghani, Payam; Stanberry, Larissa; Henry, Timothy D.; Grines, Cindy L.; Benziger, Catherine title: LB-3 | Sex Differences in Clinical Characteristics, Management Strategies and Outcomes of STEMI Patients with COVID-19 date: 2022-05-19 journal: nan DOI: 10.1016/j.jscai.2022.100321 sha: 30e22689576ec353f6379b2729f46e97c8a8ba31 doc_id: 78346 cord_uid: 3cgexvm6 nan Background: STEMI patients with COVID-19 have high mortality. Females are known to have different presentation and worse outcomes than males with STEMI. Methods: The North American COVID-19 STEMI (NACMI) registry is a prospective, multi-center registry of hospitalized STEMI patients with COVID-19 infection. We compared sex differences in clinical characteristics, management strategies and outcomes in those with confirmed COVID-19 infections. Results: Among 585 with STEMI and COVID-19, 154 (26.3%) were female. Compared to males, females were significantly older, had higher rates of diabetes and stroke/TIA and statin on admission (Table) . Males were more likely to present with chest pain whereas females presented with dyspnea. Females more often had STEMI without an identified culprit lesion. Use of primary PCI as the reperfusion strategy was significantly higher in males, whereas medical therapy was higher in females. In-hospital mortality was 33% for females and 27% for males (p¼0.217); there were also no significant sex differences in-hospital stroke or re-infarction, or composite primary endpoint. Conclusions: In the largest study of STEMI patients with COVID-19 we found significant sex differences. Females were more likely to have no culprit lesion identified and treated with medical therapy, whereas males had culprit lesion identified and treated with primary PCI. In-hospital mortality was high for both sexes. Further investigation is needed to better understand sex-differences in the underlying etiology of STEMI LB-4 j Contemporary In-Hospital Outcomes and Temporal Trends of Chronic Total Occlusion Percutaneous Coronary Interventions: Insights from the PROGRESS-CTO International Registry Minneapolis Heart Institute® -Abbott Northwestern Hospital Minneapolis Heart Institute® -Abbott Northwestern Hospital, United States; Judit Karacsonyi, Minneapolis Heart Institute® -Abbott Northwestern Hospital Khaldoon Alaswad, Henry Ford Health System Atlantic Health Morristown Medical Center Massachusetts General Hospital Cleveland Clinic Main Campus University Hospitals Cleveland Medical Center Texas Health Heart and Vascular Specialists: Presbyterian Hospital The University of California University of Colorado Health Harmony Wellstar Health System University of Arkansas for Medical Sciences Oklahoma Heart Institute, United States; Catalin Toma Northwestern Memorial Hospital North Oaks Health System Minneapolis Heart Institute® -Abbott Northwestern Hospital Minneapolis Heart Institute Foundation Minneapolis Heart Institute® -Abbott Northwestern Hospital Minneapolis Heart Institute® -Abbott Northwestern Hospital